PS

Pawan Singhal

Director Director DIN 07463827
DIN 07463827 First appointment May 2012 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since May 2012
Shareholding value Locked Premium profile

About Pawan Singhal

Data last updated:

Pawan Singhal has 14 years in corporate governance. Formerly with 1 company, such as Astrazeneca Pharma India Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07463827
Primary Designation Director
First Appointment 07 May 2012
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Astrazeneca Pharma India Limited L24231KA1979PLC003563
Company Secretary07 May 20121979Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Astrazeneca Pharma India Limited
Premium access

Shareholding and investment profile for Pawan Singhal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Singhal

Pawan Singhal has 14 years in corporate governance. Formerly with 1 company, such as Astrazeneca Pharma India Limited. Engaged in General Business. Contributes to corporate operations.

Pawan Singhal is associated with 0 companies as a director.

Pawan Singhal has expertise in General Business.

Pawan Singhal has 14 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available